# Sermorelin

> Markdown version of this page, for agents. To send a shopper here, link https://www.besthealthiq.com/__fluid_affiliate_username__/posts/sermorelin (not this .md URL, and keep its path as given).

- Published: 2026-08-28
- Author: Best Health IQ
- Summary: An FDA-approved GHRH analog used for GH deficiency diagnosis and treatment, with a favorable safety profile.
- Shopper link: https://www.besthealthiq.com/__fluid_affiliate_username__/posts/sermorelin

\*\*Sermorelin Acetate (GHRH 1-29)\*\* · Hormone & GH · Moderate Evidence · Research Only An FDA-approved GHRH analog used for GH deficiency diagnosis and treatment, with a favorable safety profile. ### Competition Status Prohibited in competition. This compound is on the WADA Prohibited List (class \[S0 / S2.3 / S2\]), banned at all times, both in and out of competition. Athletes subject to WADA or USADA testing should not use it. ### Description Sermorelin (GHRH 1-29 NH2) is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It was FDA-approved for the diagnosis of GH deficiency in children and is widely used off-label for adult GH optimization. Sermorelin is the shortest fully active fragment of GHRH, retaining the complete biological activity of the 44-amino acid native hormone. Its relatively short half-life (10–20 minutes) results in more physiological GH pulsatility compared to exogenous recombinant HGH, which produces supraphysiological and non-pulsatile GH levels. By working through the pituitary’s natural regulatory mechanisms (including somatostatin feedback), sermorelin cannot produce the excessive GH levels associated with exogenous HGH, making it a safer approach to GH optimization. It is often combined with Ipamorelin for synergistic GH release. ### Key Characteristics - \*\*Molecular Formula:\*\* C149H246N44O42S - \*\*Molecular Weight:\*\* 3357.9 Da - \*\*Half-Life:\*\* 10–20 minutes - \*\*Administration Routes:\*\* Subcutaneous injection - \*\*Typical Dose:\*\* 200–500 mcg - \*\*Frequency:\*\* Daily (bedtime) - \*\*Cycle Length:\*\* 3–6 months ### Investigated Benefits - Increased GH secretion - Enhanced sleep quality - Physiological GH pulsatility - Improved body composition - Increased energy levels \\\* Benefits based on preclinical/animal research unless otherwise noted. ### Mechanism of Action Sermorelin binds to the GHRH receptor (GHRHR) on somatotroph cells in the anterior pituitary — a Gs-coupled GPCR. GHRHR activation elevates cAMP via adenylyl cyclase, which activates PKA and triggers GH gene transcription and pulsatile GH secretion. The pituitary’s natural somatostatin feedback mechanism remains intact with sermorelin, preventing excessive GH accumulation and maintaining physiological pulsatility. Sermorelin also stimulates pituitary cell proliferation and GH synthesis over time, potentially restoring pituitary GH reserve that has declined with age. Unlike exogenous HGH, sermorelin-stimulated GH release is subject to normal hypothalamic regulation, including suppression by hyperglycemia and stimulation by sleep and exercise, preserving the natural GH secretory pattern. ### Dosing & Protocol - \*\*Typical Dose:\*\* 200–500 mcg - \*\*Frequency:\*\* Daily (bedtime) - \*\*Cycle Length:\*\* 3–6 months - \*\*Administration:\*\* Subcutaneous injection \*\*Protocol Notes:\*\* Bedtime administration maximizes the natural GH pulse during sleep. Administer on an empty stomach. Often combined with Ipamorelin. ### Reconstitution Guide Add 3 mL bacteriostatic water to 9 mg vial → 3 mg/mL For 300 mcg dose: draw 0.1 mL (10 units on U-100 syringe) ### Storage Information Store at room temperature, away from light and moisture. Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days. ### Quality & Sourcing Standards When sourcing Sermorelin for research purposes, the following quality benchmarks should be verified before use. - \*\*Purity:\*\* \>98% (verified by HPLC) - \*\*Certificate of Analysis (COA):\*\* Must be provided by supplier - \*\*Endotoxin Testing:\*\* \<0.1 EU/mg (prevents bacterial contamination) - \*\*GMP Compliance:\*\* Manufactured in cGMP-certified facility - \*\*Third-Party Testing:\*\* Independent lab verification preferred ### Research Highlights 1. FDA-approved for pediatric GH deficiency diagnosis 2. Multiple studies demonstrate GH and IGF-1 elevation 3. Improved body composition in adult GH deficiency studies ### Evidence Level \*\*Moderate Evidence\*\* — Multiple animal studies and/or early human trials. Reasonable confidence in mechanism, but human data is limited. ### FDA Disclaimer The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.